Foundation Medicine

Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases.

Our rich history of scientific firsts in comprehensive genomic profiling has changed the course of precision medicine and forged a path for high-quality genomic testing in cancer.

Drawing inspiration from our history, we are expanding our diagnostic capabilities to support the cancer care continuum. By investing in solutions to transform cancer care, from defining a diagnosis to determining the appropriate treatment to ongoing monitoring, we will improve lives today and for generations to come.

We are also accelerating the development of new personalized therapies for cancer. Our industry leading Biopharma team brings deep scientific, regulatory and quality expertise to biopharmaceutical partners to speed innovation. And we are entering into new strategic collaborations to expand beyond cancer and apply our expertise to diseases where it is most needed, and where we can make the biggest difference, including in cardiometabolic, immunologic and neurologic disorders.

Additionally, we are investing in new technologies and digital platforms, including powerful AI-enabled tools, to accelerate this scientific discovery, expand the information our diagnostic solutions provide and enable improved outcomes for patients.

As an independent affiliate of the Roche Group, we benefit from their extensive expertise, resources and global presence to impact the lives of even more people around the world.

Everyday we’re inspired to think differently to transform the lives of people living with cancer and other diseases.